Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505. [electronic resource]
Producer: 20021204Description: 1347-55 p. digitalISSN:- 0923-7534
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Confidence Intervals
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Infusions, Intravenous
- Japan
- Lenograstim
- Lymphoma, Non-Hodgkin -- diagnosis
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neutropenia -- prevention & control
- Prednisolone -- administration & dosage
- Probability
- Recombinant Proteins -- administration & dosage
- Risk Assessment
- Survival Analysis
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.